Your Rights and Protections as a Trial Participant

Clinical trials involving drugs, biologics, or medical devices are regulated by government agencies. In the United States, the Food and Drug Administration (FDA) oversees trial conduct and requires sponsors to submit detailed protocols before trials begin. In Australia, the Therapeutic Goods Administration (TGA) provides oversight, and trials may be conducted under the Clinical Trial Notification (CTN) or Clinical Trial Exemption (CTX) scheme. In Europe, the European Medicines Agency (EMA) coordinates regulatory oversight across member states. Each country also has its own national regulatory authority. These agencies can inspect trial sites, audit data, and halt trials if safety concerns arise.

Before any clinical trial can begin, the protocol must be reviewed and approved by an independent ethics committee. In the US, these are called Institutional Review Boards (IRBs). In Australia, they are Human Research Ethics Committees (HRECs). Ethics committees include doctors, scientists, and non-scientific members (including community representatives). They evaluate whether the trial design is ethical, the risks are reasonable relative to potential benefits, the informed consent process is adequate, and participant privacy is protected. Ethics committees also conduct ongoing review of active trials and can require modifications or suspend studies.

Many trials, particularly larger Phase 2 and Phase 3 studies, have an independent Data Safety Monitoring Board (DSMB). This group of experts periodically reviews accumulating data during the trial — including safety data and interim efficacy results. The DSMB can recommend continuing the trial as planned, modifying the protocol, or stopping the trial early. A trial might be stopped early because the treatment is clearly effective (making it unethical to continue the control group) or because unexpected safety issues have emerged.

As a clinical trial participant, you have the right to: • Receive a thorough explanation of the study before deciding to participate • Ask questions at any time and receive honest answers • Take time to make your decision without pressure • Withdraw from the trial at any time without penalty • Have your privacy and medical information protected • Be informed of new findings that may affect your willingness to continue • Receive appropriate medical care for any trial-related injuries • Access your own study data (in most jurisdictions) These rights are protected by law and by institutional policy. If you feel your rights are being violated, you can contact the ethics committee directly — their contact information is in your consent document.